Detalles de la búsqueda
1.
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
Haematologica
; 101(5): e196-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858355
2.
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Lancet Oncol
; 9(4): 352-8, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18342572
3.
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
J Clin Oncol
; 21(7): 1255-62, 2003 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12663712
4.
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
J Clin Oncol
; 22(13): 2654-61, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15159414
5.
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
Leuk Lymphoma
; 46(10): 1449-54, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16194890
6.
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leuk Lymphoma
; 45(9): 1815-9, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15223641
7.
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
J Clin Oncol
; 24(3): e4-5, 2006 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16421414
Resultados
1 -
7
de 7
1
Próxima >
>>